Blackstone Inc
TARA icon

Blackstone Inc’s Protara Therapeutics TARA Stock Holding History

Blackstone Inc’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.65M Hold
2,265,514
– – 0.03% 103
2026
Q1 		$11.8M Buy
2,265,514
+355,852
+19% +$2.11M 0.05% 78
2025
Q4 		$10.2M Hold
1,909,662
– – 0.04% 97
2025
Q3 		$8.31M Hold
1,909,662
– – 0.03% 101
2025
Q2 		$5.79M Buy
1,909,662
+165,620
+9% +$571K 0.02% 99
2025
Q1 		$7.43M Buy
1,744,042
+64,042
+4% +$286K 0.03% 86
2024
Q4 		$8.87M Buy
+1,680,000
New +$5.43M 0.04% 77

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Blackstone Inc's TARA Position: Q2 2026 in Review

Blackstone Inc held its Protara Therapeutics (TARA) position steady in Q2 2026 at 2,265,514 shares worth $8.65M. The position accounts for 0.03% of the portfolio, ranked #103.

Blackstone Inc first reported a position in TARA in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.8M in Q1 2026. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Blackstone Inc held 2,265,514 shares of Protara Therapeutics worth $8.65M as of Q2 2026.
  • Blackstone Inc left its Protara Therapeutics share count unchanged in Q2 2026.
  • Protara Therapeutics made up 0.03% of Blackstone Inc's portfolio in Q2 2026, its #103 holding.
  • Blackstone Inc first reported a position in Protara Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Blackstone Inc's Protara Therapeutics position peaked at $11.8M in Q1 2026.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Blackstone Inc's 13F filing for Q2 2026, filed 14 Aug 2026.